NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)

 

This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements will improve the detection of antibiotic resistance among enteric bacteria in food commodities, as well as potentially develop new sites as part of the program. Measurable outcomes of the program will be in alignment with the NARMS Objectives.

Active PAR-16-099 Agency: Department of Health and Human Services
Office: Food and Drug Administration Cooperative Agreement 30 Foreign Institutions: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed. This announcement has multiple deadline dates. May 2, 2016, by 11:59 PM Eastern Time. May 1, 2017, 2018, 2019, 2020, by 11:59 PM Eastern Time. Please refer to full announcement for details. 05/01/2020 This program does not have cost sharing or matching requirements. Bryce Jones
Grants Management Specialist
Phone 240-402-2111 http://grants.nih.gov/grants/guide/pa-files/PAR-16-099.html Bryce.Jones@fda.hhs.gov $2,500,000.00 Awards up to $160,000.00